|Articles|January 1, 1999

January 1999
Volume 5
Issue 1

Safety and Efficacy of Metformin in a Restricted Formulary

Author(s)Arthur L. M. Swislocki, MD, Quan Khuu, Ellen Liao

Download PDF: Safety and Efficacy of Metformin in a Restricted Formulary

Articles in this issue

over 27 years ago

Article

The Cost Effectiveness of Patient-Applied Versus Provider-Administered Intervention Strategies for the Treatment of External Genital Warts

over 27 years ago

Article

Medical Nutrition Therapy: A Powerful Tool in Disease Management

over 27 years ago

Article

Maintenance Drug Therapy of Chronic Obstructive Pulmonary Disease

over 27 years ago

Article

Correspondence regarding, "Compliance with Antihypertensive Therapy: Raising the Bar of Expectations"

over 27 years ago

Article

Obstacles to Early Discharge After Cardiac Surgery

over 27 years ago

Article

A Community Hospital-Based Congestive Heart Failure Program: Impact on Length of Stay, Admission and Readmission Rates, and Cost

over 27 years ago

Article

Integrating Healthcare for Older Populations

over 27 years ago

Article

Antibiotic Therapy of Helicobacter pylori Infection Reduces Healthcare Expenditures Related to Duodenal Ulcer

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Safety and Efficacy of Metformin in a Restricted Formulary

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

COVID-19 May Follow A Different Seasonal Pattern Than Influenza, RSV

What Comes Next: Taking on Unanswered Questions in Multiple Myeloma

New Bill Would Cap Traditional Medicare Out-of-Pocket Costs at $5000

FDA Expands Risankizumab Approval to Pediatric Plaque Psoriasis, Active PsA

Treatment for Thyroid Eye Disease Approved by FDA